NCT05304650View on ClinicalTrials.gov

A Usability Study of External Neuromodulation With iTEAR100 Generation 2

PHASE4UnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

April 30, 2022

Study Completion Date

June 15, 2022

Conditions
Dry Eye Syndromes
Interventions
DEVICE

iTEAR100

Controlled Stimulation External Nasal Nerve to stimulate tear production

Trial Locations (1)

98027

RECRUITING

Olympic Ophthalmics, Issaquah

Sponsors
All Listed Sponsors
lead

Olympic Ophthalmics, Inc.

INDUSTRY

NCT05304650 - A Usability Study of External Neuromodulation With iTEAR100 Generation 2 | Biotech Hunter | Biotech Hunter